Common Stock, Shares, Issued of Cartesian Therapeutics, Inc. from 31 Dec 2015 to 31 Dec 2025

Taxonomy & unit: us-gaap: shares
Description: Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary: Cartesian Therapeutics, Inc. quarterly Common Stock, Shares, Issued in shares history and change rate from 31 Dec 2015 to 31 Dec 2025.
Cartesian Therapeutics, Inc. Common Stock, Shares, Issued for the quarter ending 31 Dec 2025 was 26,011,106, a 0.95% increase year-over-year.
Source SEC data: View on sec.gov

Common Stock, Shares, Issued, Quarterly (shares)

Common Stock, Shares, Issued, YoY Quarterly Change (%)

Cartesian Therapeutics, Inc. Quarterly Common Stock, Shares, Issued (shares)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q4 2025	26,011,106	+243,737	+0.95%	31 Dec 2025	10-K	09 Mar 2026	2025	FY
Q3 2025	26,003,606	+2,107,081	+8.8%	30 Sep 2025	10-Q	06 Nov 2025	2025	Q3
Q2 2025	26,000,065	+8,183,827	+46%	30 Jun 2025	10-Q	07 Aug 2025	2025	Q2
Q1 2025	25,936,101	+20,420,265	+370%	31 Mar 2025	10-Q	08 May 2025	2025	Q1
Q4 2024	25,767,369	+20,369,772	+377%	31 Dec 2024	10-K	09 Mar 2026	2025	FY
Q3 2024	23,896,525	-130,957,507	-85%	30 Sep 2024	10-Q	07 Nov 2024	2024	Q3
Q2 2024	17,816,238	-135,611,333	-88%	30 Jun 2024	10-Q	08 Aug 2024	2024	Q2
Q1 2024	5,515,836	-147,911,147	-96%	31 Mar 2024	10-Q	08 May 2024	2024	Q1
Q4 2023	5,397,597	-147,644,838	-96%	31 Dec 2023	10-K	13 Mar 2025	2024	FY
Q3 2023	154,854,032	+1,825,210	+1.2%	30 Sep 2023	10-Q	13 Nov 2023	2023	Q3
Q2 2023	153,427,571	+714,360	+0.47%	30 Jun 2023	10-Q	17 Aug 2023	2023	Q2
Q1 2023	153,426,983	+29,046,139	+23%	31 Mar 2023	10-Q	04 May 2023	2023	Q1
Q4 2022	153,042,435	+29,419,470	+24%	31 Dec 2022	10-K	07 Mar 2024	2023	FY
Q3 2022	153,028,822	+37,585,322	+33%	30 Sep 2022	10-Q	03 Nov 2022	2022	Q3
Q2 2022	152,713,211	+37,633,919	+33%	30 Jun 2022	10-Q	08 Aug 2022	2022	Q2
Q1 2022	124,380,844	+11,403,840	+10%	31 Mar 2022	10-Q	05 May 2022	2022	Q1
Q4 2021	123,622,965	+15,551,716	+14%	31 Dec 2021	10-K	02 Mar 2023	2022	FY
Q3 2021	115,443,500	+8,207,524	+7.7%	30 Sep 2021	10-Q	09 Nov 2021	2021	Q3
Q2 2021	115,079,292	+14,231,482	+14%	30 Jun 2021	10-Q	12 Aug 2021	2021	Q2
Q1 2021	112,977,004	+25,957,832	+30%	31 Mar 2021	10-Q	13 May 2021	2021	Q1
Q4 2020	108,071,249	+21,745,702	+25%	31 Dec 2020	10-K	10 Mar 2022	2021	FY
Q3 2020	107,235,976	+59,039,589	+122%	30 Sep 2020	10-Q	05 Nov 2020	2020	Q3
Q2 2020	100,847,810	+55,894,859	+124%	30 Jun 2020	10-Q	06 Aug 2020	2020	Q2
Q1 2020	87,019,172	+42,231,147	+94%	31 Mar 2020	10-Q	07 May 2020	2020	Q1
Q4 2019	86,325,547	+63,853,771	+284%	31 Dec 2019	10-K	12 Mar 2021	2020	FY
Q3 2019	48,196,387	+25,800,204	+115%	30 Sep 2019	10-Q	08 Nov 2019	2019	Q3
Q2 2019	44,952,951	+22,556,768	+101%	30 Jun 2019	10-Q	08 Aug 2019	2019	Q2
Q1 2019	44,788,025	+22,438,185	+100%	31 Mar 2019	10-Q	09 May 2019	2019	Q1
Q4 2018	22,471,776	+128,522	+0.58%	31 Dec 2018	10-K	12 Mar 2020	2019	FY
Q3 2018	22,396,183	+275,676	+1.2%	30 Sep 2018	10-Q	08 Nov 2018	2018	Q3
Q2 2018	22,396,183	+340,036	+1.5%	30 Jun 2018	10-Q	08 Aug 2018	2018	Q2
Q1 2018	22,349,840	+3,797,455	+20%	31 Mar 2018	10-Q	09 May 2018	2018	Q1
Q4 2017	22,343,254	+3,904,512	+21%	31 Dec 2017	10-K	15 Mar 2019	2018	Q4
Q3 2017	22,120,507	+3,930,327	+22%	30 Sep 2017	10-Q	07 Nov 2017	2017	Q3
Q2 2017	22,056,147	+4,155,600	+23%	30 Jun 2017	10-Q	11 Aug 2017	2017	Q2
Q1 2017	18,552,385			31 Mar 2017	10-Q	11 May 2017	2017	Q1
Q4 2016	18,438,742	+16,257,766	+745%	31 Dec 2016	10-K	15 Mar 2018	2017	Q4
Q3 2016	18,190,180			30 Sep 2016	10-Q	10 Nov 2016	2016	Q3
Q2 2016	17,900,547			30 Jun 2016	10-Q	09 Aug 2016	2016	Q2
Q4 2015	2,180,976			31 Dec 2015	10-K	28 Mar 2017	2016	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.